真菌性/感染性自体主动脉瘤:优先开放手术与动脉同种异体移植后的结果
该回顾性研究纳入2002年9月至2020年3月两家机构的70例感染性自体主动脉瘤患者,94%接受开放手术,96%使用冷冻保存动脉同种异体移植。院内死亡率为27.9%(95%CI 1.8-66.5),感染相关并发症发生率为10%。慢性肾病与院内死亡独立相关(OR 20.7,95%CI 1.8-232.7)。
要点
- 感染性自体主动脉瘤开放手术死亡率和再感染率均较高。
- 冷冻保存动脉同种异体移植是主要血管替代物(96%)。
- 慢性肾病与院内死亡独立相关(OR 20.7,95%CI 1.8-232.7)。
核心结论
- 感染性自体主动脉瘤外科治疗死亡率显著,再感染率低。
- EVAR需二次开放手术,但本报告使用有限,无法得出结论。
研究设计与样本
- 回顾性综述,纳入2002年9月至2020年3月两家机构收治的感染性自体主动脉瘤患者70例(男性60例[86%],中位年龄68岁[范围59-76岁])。
- 研究终点为院内死亡、90天死亡、总死亡和感染相关并发症(IRCs)。
主要发现
- 20例(29%)就诊时破裂;瘤体位置胸主动脉11例(16%)、胸腹主动脉7例(10%)、腹主动脉50例(71%),腹主动脉瘤中半数位于肾动脉以上,2例同时累及腹主动脉和胸主动脉。
- 83%患者检出病原体,细菌谱分散,沙门菌属少见(n=6;9%)。
- 66例(94%)行开放手术修复,包括5例初期尝试EVAR后中转开放、3例杂交手术和1例姑息性EVAR;血管替代物为冷冻保存动脉同种异体移植67例(96%)、人工血管2例、股静脉1例。
- Kaplan-Meier估计30天和90天总生存率分别为87%(95%CI 76.6-93.0)和71.7%(95%CI 59.2-80.9);院内总死亡率为27.9%(95%CI 1.8-66.5);IRCs发生于7例(10%)患者;中位随访26.5个月(范围13.0-66.0个月)。
- 慢性肾病(CKD)与院内死亡独立相关(OR 20.7,95%CI 1.8-232.7);美国麻醉医师协会评分3分(OR 6.0,95%CI 1.1-33.9)、4分(OR 14.9,95%CI 1.7-129.3)及CKD(OR 32.0,95%CI 1.2-821.5)与90天死亡相关。
局限性
- EVAR在本报告中使用有限,无法得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Mycotic/infective native aortic aneurysms (INAA) are managed heterogeneously. In the context of disparate literature, this study aimed to assess the outcomes of INAA surgical management and provide comprehensive data in alignment with recent suggestions for reporting standards. METHODS: A retrospective review of patients presenting with INAA from September 2002 to March 2020 at two institutions was conducted. In hospital mortality, 90 day mortality, overall mortality, and infection related complications (IRCs) were the study endpoints. Overall survival and IRC free survival were estimated, and predictors of mortality tested using uni- and multivariable analyses. RESULTS: Seventy patients (60 men [86%], median age 68 years [range 59 - 76 years]) were included. Twenty (29%) were ruptured at presentation. INAA location was thoracic in 11 (16%) cases, thoraco-abdominal in seven (10%), and abdominal in 50 (71%). Half of the abdominal INAAs were suprarenal. Two INAAs were concomitantly abdominal and thoracic. Pathogens were identified in 83%. The bacterial spectrum was scattered, with rare Salmonella species (n = 6; 9%). Open surgical repair was performed in 66 (94%) patients, including five conversions of initially attempted endovascular grafts (EVAR), three hybrid procedures, and one palliative EVAR. Vascular substitutes were cryopreserved arterial allografts (n = 67; 96%), prosthesis (n = 2), or femoral veins (n = 1). Kaplan-Meier estimates of overall survival at 30 and 90 days were 87% (95% confidence interval [CI] 76.6 - 93.0) and 71.7% (95% CI 59.2 - 80.9), respectively. The overall in hospital mortality rate was 27.9% (95% CI 1.8 - 66.5). IRCs occurred in seven (10%) patients. The median follow up period was 26.5 months (range 13.0-66.0 months). Chronic kidney disease (CKD) was independently related to in hospital mortality (odds ratio [OR] 20.7, 95% CI 1.8 - 232.7). American Society of Anesthesiologists score of 3 (OR 6.0, 95% CI 1.1 - 33.9), 4 (OR 14.9, 95% CI 1.7 - 129.3), and CKD (OR 32.0, 95% CI 1.2 - 821.5) were related to 90 day mortality. CONCLUSION: Surgical INAA management has significant mortality and a low re-infection rate. EVAR necessitated secondary open repair, but its limited use in this report did not allow conclusions to be drawn.
引用
- Touma J, Couture T, Davaine JM, et al. Mycotic/Infective Native Aortic Aneurysms: Results After Preferential Use of Open Surgery and Arterial Allografts. Eur J Vasc Endovasc Surg. 2021. PMID: 34872811. doi:10.1016/j.ejvs.2021.10.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。